Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 9
- 主要终点
- Coronavirus sequencing
研究概览
简要总结
The objectives of this study are to characterise immune responses in people with CoV-SARS-2 infection and use this knowledge to advance vaccine design, treatment options, and diagnostic reagents. Eligible participants will include people diagnosed with SARS-CoV-2 infection, and may include recently returned travellers and non-travellers in the community presenting to tertiary hospital healthcare facilities. Recruitment will be opportunistic, and sampling intensity may vary depending on the phase of the outbreak. Participants can be enrolled at any timepoint (up to 6 months) following diagnosis of SARS-CoV-2 infection (COVID-19). Blood samples and clinical data will be collected.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Main cohort
- •Diagnosed with CoV-SARS-2 infection
- •16 years of age or older
- •Have provided informed consent Paediatric cohort
- •Diagnosed with CoV-SARS-2 infection
- •Less than 16 years of age
- •Informed consent provided by parent or caregiver
排除标准
- •Main cohort
- •15 years of age or younger
- •Inability or unwillingness to provide informed consent or abide by the requirements of the study Paediatric cohort
- •16 years of age or older
- •Inability or unwillingness of parent or caregiver to provide informed consent or abide by the requirements of the study -
结局指标
主要结局
Coronavirus sequencing
时间窗: 4 months post COVID-19 diagnosis.
The viruses will be sequenced to to help understand epitope specificity
次要结局
- Coronavirus culturing(4 months post COVID-19 diagnosis.)